Neuronetics, Inc., a
privately-held medical device company and a leader in the field of
neuromodulation, announced today that the U.S. Food and Drug Administration
(FDA) has cleared its NeuroStar TMS (Transcranial Magnetic Stimulation)
Therapy system for the treatment of depression. NeuroStar TMS Therapy(R) is
specifically indicated for the treatment of Major Depressive Disorder in
adult patients who have failed to achieve Read the rest of this entry »